Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | PLAU | P00749 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10534797 | 0.85 | PRCP (0.41) | SIGMAR1ALDH1A1SMN1; SMN2GSK3BBCHE | |
| SCHEMBL9490322 | 0.79 | SMN1; SMN2 (0.51) | ALDH1A1TSHRSMN1; SMN2HSD17B10GSK3B | |
| SCHEMBL10534331 | 0.79 | KDM1A (0.41) | SIGMAR1SMN1; SMN2GRIN2BKDM1AMAOA | |
| SCHEMBL11129686 | 0.76 | SIGMAR1 (0.44) | SIGMAR1CYP11B2GRIN2BKDM1AMAOA | |
| SCHEMBL6414384 | 0.75 | TSHR (0.36) | SIGMAR1CYP11B2ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL6721448 | 0.75 | SIGMAR1 (0.43) | SIGMAR1TSHRPLAU | |
| SCHEMBL15547683 | 0.73 | SIGMAR1 (0.42) | SIGMAR1CYP11B2TSHRGRIN2BPLAU | |
| SCHEMBL30724832 | 0.73 | SIGMAR1 (0.42) | SIGMAR1GSK3BPLAU | |
| SCHEMBL10780065 | 0.73 | SIGMAR1 (0.42) | SIGMAR1GSK3BPLAU | |
| SCHEMBL6676676 | 0.73 | PLAU (0.45) | SIGMAR1PLAU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3602046-A1 | METHODS FOR DETECTION OF TAU PROTEIN AGGREGATION MODULATING COMPOUNDS | Janssen Vaccines & Prevention B.V. (NL) | 2020-02-05 | — | — | EP | claimed |
| WO-2018178080-A1 | METHODS FOR DETECTION OF TAU PROTEIN AGGREGATION MODULATING COMPOUNDS | JANSSEN VACCINES & PREVENTION B.V. (NL) | 2018-10-04 | — | — | WO | claimed |
| WO-2015188142-A1 | DIAGNOSIS AND MONITORING OF TRAUMATIC BRAIN INJURY BY IMAGING RETINAL ABNORMALITIES | CEDARS-SINAI MEDICAL CENTER (US) | 2015-12-10 | — | — | WO | claimed |
| EP-2938636-A2 | HIGH-THROUGHPUT SYSTEM AND METHOD FOR IDENTIFYING ANTIBODIES HAVING SPECIFIC ANTIGEN BINDING ACTIVITIES | AbbVie Inc. (US) | 2015-11-04 | — | — | EP | claimed |
| EP-2875350-A1 | MANIPULATION OF MICROPARTICLES IN LOW FIELD DIELECTROPHORETIC REGIONS | Biological Dynamics, Inc. (US) | 2015-05-27 | — | — | EP | claimed |
| WO-2014106004-A2 | HIGH-THROUGHPUT SYSTEM AND METHOD FOR IDENTIFYING ANTIBODIES HAVING SPECIFIC ANTIGEN BINDING ACTIVITIES | ABBVIE, INC. (US) | 2014-07-03 | — | — | WO | claimed |
| WO-2014015187-A1 | MANIPULATION OF MICROPARTICLES IN LOW FIELD DIELECTROPHORETIC REGIONS | BIOLOGICAL DYNAMICS, INC. (US) | 2014-01-23 | — | — | WO | claimed |
| EP-2217259-A2 | METHODS FOR TREATMENT OF THIOL-CONTAINING COMPOUND DEFICIENT CONDITIONS | National Jewish Health (US) | 2010-08-18 | — | — | EP | claimed |
| WO-2010062377-A2 | METHODS AND COMPOSITIONS FOR THE DETECTION AND TREATMENT OF PREECLAMPSIA | YALE UNIVERSITY (US) | 2010-06-03 | — | — | WO | claimed |
| WO-2009052411-A2 | METHODS FOR TREATMENT OF THIOL-CONTAINING COMPOUND DEFICIENT CONDITIONS | NATIONAL JEWISH MEDICAL AND RESEARCH CENTER (US) | 2009-04-23 | — | — | WO | claimed |
| EP-1251855-A1 | SELECTIVE ESTROGEN RECEPTOR MODULATORS IN COMBINATION WITH ESTROGENS | Endorecherche, Inc. (CA) | 2002-10-30 | — | — | EP | claimed |
| WO-2001054699-A1 | SELECTIVE ESTROGEN RECEPTOR MODULATORS IN COMBINATION WITH ESTROGENS | ENDORECHERCHE, INC. (CA) | 2001-08-02 | — | — | WO | claimed |
| WO-2024112231-A1 | COMPOSITION OF FAST-ACTING INSULIN (VARIANTS) | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ГЕРОФАРМ" | 2024-05-30 | — | — | WO | disclosed |
| EP-4285994-A2 | METHODS FOR THE PREVENTION OR TREATMENT OF NO-REFLOW FOLLOWING ISCHEMIA/REPERFUSION INJURY | Stealth BioTherapeutics Inc. (US) | 2023-12-06 | — | — | EP | disclosed |
| WO-2023161211-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | Technische Universität München (DE) | 2023-08-31 | — | — | WO | disclosed |
| WO-2022159641-A1 | METHOD FOR TREATING HEPATOCELLULAR CARCINOMA | ACADEMIA SINICA (TW) | 2022-07-28 | — | — | WO | disclosed |
| EP-0343380-A1 | Method and agent to differentiate between and to determine leucocytes | MERCK PATENT GmbH (DE) | 1989-11-29 | — | — | EP | disclosed |
| US-4801593-A | VIRICIDE FOR RHINITIS VIRUS CONTAINING 2-PHENYLTETRALIN DERIVATIVE | BURROUGHS WELLCOME CO. (US) | 1989-01-31 | — | — | US | disclosed |
| EP-0025598-B1 | THE USE OF 2-PHENYLTETRALIN DERIVATIVES, OR HETEROCYCLIC ANALOGUES, IN MEDICINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | THE WELLCOME FOUNDATION LIMITED (GB) | 1984-08-01 | — | — | EP | disclosed |
| EP-0025598-A1 | The use of 2-phenyltetralin derivatives, or heterocyclic analogues, in medicine and pharmaceutical compositions containing them | THE WELLCOME FOUNDATION LIMITED (GB) | 1981-03-25 | — | — | EP | disclosed |